The Russian government plans to significantly reduce public procurements of cancer drugs in 2027, that will be mainly due to ...

Italy's Sibylla Biotech, an oncology firm developing small-molecule protein degraders that interfere with protein folding, ...

The UK Medicines and Healthcare products Regulatory Agency (MHRA) today authorised Onswik (insulin efsitora alfa) for the ...

US biotech companies Bambusa Therapeutics and Aspen Neuroscience have filed for initial public offerings (IPOs), seeking ...

US clinical-stage biotech Tortugas Neuroscience has announced positive Phase IIb trial results for obuprazine (TRTL-107), the ...

Telix Pharmaceuticals (ASX: TLX) began US commercial supply of Pixclara (floretyrosine F 18), while Knight Therapeutics (TSX: ...

Canadian eye health company Bausch + Lomb (NYSE: BLCO) has appointed Thomas Appio interim chief executive following an ...

Boston, USA-based computational drug discovery company Nimbus Therapeutics has made three senior appointments as it expands ...

New US cancer indications and an antiviral approval featured among human medicines regulatory updates from October 6 to 12, ...

US rare diseases biotech Mirum Pharmaceuticals today announced top-line results from the Phase III EXPAND study evaluating ...

Governor Josh Shapiro and Department of Community and Economic Development (DCED) Secretary Rick Siger announced the ...

Uptake of new cancer medicines still differs more than three-fold between European countries, though the gap has narrowed ...